EEG/ERP Biomarker Qualification Consortium (EBQC) aims to qualify, validate, and operationalize EEG/ERP biomarkers for use in CNS clinical trials. EBQC brings together a diverse group of stakeholders (industry, academic, regulatory) in the spirit of pre-competitive cooperation to ensure that robust and reliable EEG/ERP biomarkers can be implemented in clinical trials.
Company Details
- Employees
- 1
- Address
- Boston, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://erpbiomarkers.org
- Keywords
- EEG, electroencephalography, neuroscience, mental health, clinical research, clinical trials, pharmaceuticals, psychiatry, neurology, biotechnology, digital health, biomarkers.
- HQ
- Boston, MA
Eeg/erp Biomarker Qualification Consortium Questions
Eeg/Erp Biomarker Qualification Consortium's website is https://erpbiomarkers.org
Eeg/Erp Biomarker Qualification Consortium's LinkedIn profile is https://www.linkedin.com/company/ebqc
Eeg/Erp Biomarker Qualification Consortium has
1 employees.
View email and phone details for 1
employees at Eeg/Erp Biomarker Qualification Consortium.
Eeg/Erp Biomarker Qualification Consortium's industry is
Biotechnology Research
Eeg/Erp Biomarker Qualification Consortium's top competitors are
Brainformatika,
Cognision,
Deeppsy Ag,
Cebreo Medical A/s,
Foundation For The National Institutes Of Health,
Cns Summit,
Neumarker Inc.,
Isctm,
Schizophrenia International Research Society (Sirs),
Otsuka Pharmaceutical Co., Ltd..
Eeg/Erp Biomarker Qualification Consortium's categories are Biotechnology Research
